Sugi Predict

Sugi Predict / Compounds / SCHEMBL574079

SCHEMBL574079

SCHEMBL574079

CCC(C)C(C)(N)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ GGT1 P19440 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TSHR P16473 2/20 0.33
▸ KIF11 P52732 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ CYP2D6 P10635 2/20 0.32
▸ ARG1 P05089 2/20 0.32
▸ ARG2 P78540 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ GRM2 Q14416 1/20 0.32
▸ GRM3 Q14832 1/20 0.32
▸ CA1 P00915 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29489674 1.00 ALDH1A1 (0.34) ALDH1A1CYP1A2GGT1MEN1THRB
SCHEMBL22636108 1.00 ALDH1A1 (0.34) ALDH1A1CYP1A2GGT1MEN1THRB
SCHEMBL202556 1.00 ALDH1A1 (0.34) ALDH1A1CYP1A2GGT1MEN1THRB
SCHEMBL20854287 1.00 ALDH1A1 (0.34) ALDH1A1CYP1A2GGT1MEN1THRB
SCHEMBL162434 1.00 ALDH1A1 (0.34) ALDH1A1CYP1A2GGT1MEN1THRB
SCHEMBL18274694 0.83 GABRR1 (0.36) ALDH1A1CYP1A2GGT1TSHRNOS1
SCHEMBL5322047 0.83 GABRR1 (0.36) ALDH1A1CYP1A2GGT1TSHRNOS1
SCHEMBL20854183 0.82 CHRM1 (0.44) ALDH1A1CYP1A2GGT1MEN1THRB
SCHEMBL20854296 0.82 CHRM1 (0.44) ALDH1A1CYP1A2GGT1MEN1THRB
SCHEMBL18770575 0.81 CA1 (0.35) KIF11CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160318987-A1 PROTEASE RESISTANT PEPTIDES MEDIMMUNE LIMITED (GB) 2016-11-03 — — US claimed
EP-3080153-A2 PROTEASE RESISTANT PEPTIDES Medimmune Limited (GB) 2016-10-19 — — EP claimed
WO-2015086686-A2 PROTEASE RESISTANT PEPTIDES MEDIMMUNE LIMITED (GB) 2015-06-18 — — WO claimed
CN-1886363-A Amino acids with affinity for the alpha2delta-protein WARNER LAMBERT CO (US) 2006-12-27 — — CN claimed
CN-1578786-A Linear basic compounds having NK-2 antagonistic activity and formulations thereof MENARINI RICERCHE SPA (IT) 2005-02-09 — — CN claimed
US-20040259930-A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof MALESCI INSTITUTO FARMACOBIOLOGICO S.P.A. (IT) 2004-12-23 — — US claimed
EP-3966226-B1 MASP INHIBITORY COMPOUNDS AND USES THEREOF BAYER AG (DE) 2025-12-24 — — EP disclosed
US-12503491-B2 MASP inhibitory compounds and uses thereof BAYER AKTIENGESELLSCHAFT (DE) 2025-12-23 — — US disclosed
CN-114585637-B MASP-inhibitory compounds and uses thereof 拜耳公司 2025-04-15 — — CN disclosed
US-20240201179-A1 FLUOROGENIC SENSORS FOR DETECTING ANTIGENS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-06-20 — — US disclosed
WO-2024119049-A1 COMPOSITIONS AND METHODS FOR PROTEIN INTERNALIZATION LYTICA THERAPEUTICS, INC. (US) 2024-06-06 — — WO disclosed
US-20240182532-A1 MICROPEPTIDES AND USES THEREOF FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (ES) 2024-06-06 — — US disclosed
US-20240174723-A1 STAPLED ANTIMICROBIAL PEPTIDES (STAMPS) AND USES THEREOF LYTICA THERAPEUTICS, INC. (US) 2024-05-30 — — US disclosed
EP-1442050-A2 LINEAR BASIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTIVITY AND FORMULATIONS THEREOF MALESCI ISTITUTO FARMACOBIOLOGICO S.p.A. (IT) 2004-08-04 — — EP disclosed
WO-2003037916-A2 LINEAR BASIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTIVITY AND FORMULATIONS THEREOF MALESCI ISTITUTO FARMACOBIOLOGICO S.P.A. (IT) 2003-05-08 — — WO disclosed
CN-1351663-A Viral variants NORTH WESTER HEALTH CARE NETWO (AU) 2002-05-29 — — CN disclosed
WO-1997047313-A1 TOTAL SYNTHESIS OF BACITRACIN POLYPETIDES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 1997-12-18 — — WO disclosed
EP-0169300-B1 PROCESS FOR PREPARATION OF ALPHA-ALKYL AMINO ACIDS MERCK & CO. INC. (US) 1988-05-25 — — EP disclosed
EP-0169300-A1 Process for preparation of alpha-alkyl amino acids MERCK & CO. INC. (US) 1986-01-29 — — EP disclosed
US-4508921-A Process for preparation of alpha-alkyl amino acids MERCK & CO., INC. (US) 1985-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503491-B2 MASP inhibitory compounds and uses thereof MASP2, SERPINB1, SPINT2 ALDH1A1 2138/4885CYP1A2 4511/4885GGT1 1081/4885
US-20240201179-A1 FLUOROGENIC SENSORS FOR DETECTING ANTIGENS CD2BP2, CD69, LY96 ALDH1A1 4679/4885CYP1A2 4881/4885GGT1 983/4885
US-20240174723-A1 STAPLED ANTIMICROBIAL PEPTIDES (STAMPS) AND USES THEREOF NGLY1, MDN1, SPPL2B ALDH1A1 4795/4885CYP1A2 4845/4885GGT1 2173/4885
US-20040259930-A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof BDKRB2, BDKRB1, TACR2 ALDH1A1 2231/4885CYP1A2 1905/4885GGT1 4055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.